Skip to search formSkip to main contentSkip to account menu
You are currently offline. Some features of the site may not work correctly.

Stage IV Hodgkin Lymphoma

Known as: Stage IV Hodgkin's Lymphoma, Stage IV Hodgkin's Disease, Hodgkin's Disease Stage IV 
Ann Arbor Classification: Stage IV: Diffuse or disseminated involvement of one or more extralymphatic organs, with or without associated lymph node… Expand
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2020
2020
CD27, a costimulatory molecule on T cells, induces intracellular signals mediating cellular activation, proliferation, effector… Expand
  • figure 1
  • figure 2
  • table 1
  • figure 3
  • figure 4
2019
2019
threatening rise in the serum potassium level to 10.0 mmol/L, even in the normal kidney function; the emergency was successfully… Expand
2019
2019
The most recent progress in the oncology field has led to a paradigm shift in the management of cancer with the tsunami of immune… Expand
  • figure 1
  • figure 2
  • figure 3
2019
2019
Skeletal muscle involvement in Hodgkin lymphoma is very rare. An 11-year male child presented with stage IV Hodgkin lymphoma and… Expand
  • figure 1
Review
2018
Review
2018
Detecting extranodal disease in paediatric Hodgkin lymphoma is of great importance for both treatment and prognosis. Different… Expand
  • table 1
  • table 2
  • figure 1
  • figure 3
  • figure 4
2018
2018
Calcinosis cutis results from the deposition of insoluble calcium salts in the skin and subcutaneous tissue. Herein, we report a… Expand
Review
2017
Review
2017
We report a case of a grade 3 (Common Terminology Criteria for Adverse Events [CTCAE]) infusion reaction to brentuximab vedotin… Expand
2016
2016
BACKGROUND Anthracyclines are effective drugs in pediatrics cancer treatment. However, anthracycline-induced cardiotoxicity (AIC… Expand
2015
2015
We thank Adams and colleagues ([1][1]) for their continued interest in our research. We feel that discussions within the… Expand
Review
2009
Review
2009
BACKGROUND AND OBJECTIVES While treatment outcomes for patients with Hodgkin lymphoma (HL) have improved remarkably, patients… Expand